
About BioSphings
BioSphings was a Healthcare company based in Frankfurt (Germany) founded in 2001. A German mid-clinical stage biopharma developing innovative therapeutics for cancer, autoimmune diseases, and viral infections. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biopharmaceuticals, Therapeutics Development and Oncology and Immunology.
Company details
BioSphings a german mid-clinical stage biopharma developing innovative therapeutics for cancer, autoimmune diseases, and viral infections through providing healthcare solutions, biopharmaceuticals, therapeutics development, and oncology and immunology. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
- Headquarters Frankfurt, Germany
- SectorsHealthcare
- Website biosphings.com
Web traffic of BioSphings
Websites that share an audience with BioSphings (biosphings.com).
Websites whose visitors overlap most with BioSphings. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medigene.com | 100% | 1.1K | #13,562,665 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioSphings
BioSphings was founded in 2001.
BioSphings is headquartered in Frankfurt, Germany. It is registered at Frankfurt, Hesse, Germany.
BioSphings a german mid-clinical stage biopharma developing innovative therapeutics for cancer, autoimmune diseases, and viral infections through providing healthcare solutions, biopharmaceuticals, therapeutics development, and oncology and immunology. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.